In addition, studies based on mouse models indicate that individual overexpression of FGF19 and/or FGFR4 are not the only risk factors for HCC and other cancer types since FGFR4 hyperactivation mediated by abnormal FGF19 expression and, consequently, signaling is just an important issue [68]. The gene discussed is FGFR4; the disease is cancer.